Small-cell lung cancer patients are just 'a little bit' tired: response shift and self-presentation in the measurement of fatigue

被引:35
|
作者
Westerman, Marjan J.
The, Anne-Mei
Sprangers, Mirjam A. G.
Groen, Harry J. M.
van der Wal, Gerrit
Hak, Tony
机构
[1] VU Univ, Ctr Med, Dept Publ & Occupat Hlth, EMGO Inst, NL-1081 BT Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Psychol Med, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Groningen Hosp, Dept Pulm Dis, Groningen, Netherlands
[4] Erasmus Univ, RSM, Rotterdam, Netherlands
关键词
small-cell lung cancer; quality of life; response shift; self-presentation; fatigue;
D O I
10.1007/s11136-007-9178-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Response shift has gained increasing attention in the measurement of health-related quality of life (QoL) as it may explain counter-intuitive findings as a result of adaptation to deteriorating health. Objective To search for response shift type explanations to account for counter-intuitive findings in QoL measurement. Methods Qualitative investigation of the response behaviour of small-cell lung cancer (SCLC) patients (n = 23) in the measurement of fatigue with The European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) question 'were you tired'. Interviews were conducted at four points during 1st line chemotherapy: at the start of chemotherapy, 4 weeks later, at the end of chemotherapy, and 6 weeks later. Patients were asked to 'think aloud' when filling in the questionnaire. Results Fifteen patients showed discrepancies between their answer to the EORTC question 'were you tired' and their level of fatigue spontaneously reported during the interview. These patients chose the response options 'not at all' or 'a little' and explained their answers in various ways. In patients with and without discrepancies, we found indications of recalibration response shift (e.g. using a different comparison standard over time) and of change in perspective (e.g. change towards a more optimistic perspective). Patients in the discrepancy group reported spontaneously how they dealt with diagnosis and treatment, i.e. by adopting protective and assertive behaviour and by fighting the stigma. They distanced themselves from the image of the stereotypical cancer patient and presented themselves as not suffering and accepting fatigue as consequence of treatment. Conclusion In addition to response shift, this study suggests that 'self-presentation' might be an important mechanism affecting QoL measurement, particularly during phases when a new equilibrium needs to be found.
引用
收藏
页码:853 / 861
页数:9
相关论文
共 50 条
  • [41] The role of prophylactic cranial irradiation for patients with small-cell lung cancer
    Nakahara, Yoshiro
    Sasaki, Jiichiro
    Fukui, Tomoya
    Otani, Sakiko
    Igawa, Satoshi
    Hayakawa, Kazushige
    Masuda, Noriyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (01) : 26 - 30
  • [42] The clinical application of atorvastatin in patients with small-cell lung cancer with dyslipidemia
    Fanming Kong
    Na Wang
    Fangfang Gao
    Yangyueying Liang
    Longhui Li
    Minghui Yu
    Lu Zhao
    Dou Zhang
    Yingjie Jia
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 13697 - 13704
  • [43] Comorbidity in Patients With Small-Cell Lung Cancer: Trends and Prognostic Impact
    Aarts, Mieke J.
    Aerts, Joachim G.
    van den Borne, Ben E.
    Biesma, Bonne
    Lemmens, Valery E. P. P.
    Kloover, Jeroen S.
    CLINICAL LUNG CANCER, 2015, 16 (04) : 282 - 291
  • [44] ROLE OF SURGERY IN PATIENTS WITH EARLY STAGE SMALL-CELL LUNG CANCER
    Li, Guoshu
    Xie, Shuanshuan
    Wang, Changhui
    RESPIROLOGY, 2019, 24 : 51 - 52
  • [45] ORAL IFOSFAMIDE AND ETOPOSIDE IN PATIENTS WITH SMALL-CELL LUNG-CANCER
    LIND, M
    CERNY, T
    THATCHER, N
    CARROLL, K
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 69 - 69
  • [46] Response to cisplatin-etoposide treatment and survival in patients with small-cell lung cancer in North Lebanon
    Kalaajieh, WK
    MEDICAL PRINCIPLES AND PRACTICE, 2003, 12 (02) : 117 - 122
  • [47] Prophylactic Cranial Irradiation for Patients With Limited-Stage Small-Cell Lung Cancer With Response to Chemoradiation
    Tai, Patricia
    Assouline, Avi
    Joseph, Kurian
    Stitt, Larry
    Yu, Edward
    CLINICAL LUNG CANCER, 2013, 14 (01) : 40 - 44
  • [48] Immunocytochemical assessment of bone marrow aspirates for monitoring response to chemotherapy in small-cell lung cancer patients
    G Pelosi
    F Pasini
    C Ottensmeier
    F Pavanel
    E Bresaola
    A Bonetti
    F Fraggetta
    A Terzi
    A Iannucci
    G L Cetto
    British Journal of Cancer, 1999, 81 : 1213 - 1221
  • [49] Immunocytochemical assessment of bone marrow aspirates for monitoring response to chemotherapy in small-cell lung cancer patients
    Pelosi, G
    Pasini, F
    Ottensmeier, C
    Pavanel, F
    Bresaola, E
    Bonetti, A
    Fraggetta, F
    Terzi, A
    Iannucci, A
    Cetto, GL
    BRITISH JOURNAL OF CANCER, 1999, 81 (07) : 1213 - 1221
  • [50] DIGITAL GANGRENE IN SMALL-CELL LUNG-CANCER - RESPONSE TO ASPIRIN TREATMENT
    ARROWSMITH, JE
    WOODHEAD, MA
    BEVAN, DH
    NANSON, EM
    CUMMIN, ARC
    THORAX, 1991, 46 (01) : 63 - 64